Patents by Inventor Erin Marie Scott

Erin Marie Scott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250011735
    Abstract: Provided is a nucleic acid comprising a recombinant bacterial or archaeal geranyl pyrophosphate synthase (GPPS) gene, codon optimized for production in yeast. Also provided is a yeast cell comprising an expression cassette comprising the above nucleic acid. Additionally provided is a method of producing a terpene or cannabinoid in a yeast, the method comprising incubating the above yeast cell in a manner sufficient to produce the terpene or cannabinoid.
    Type: Application
    Filed: January 26, 2022
    Publication date: January 9, 2025
    Applicant: CB Therapeutics, Inc.
    Inventors: Erin Marie Scott, Kirsten Tang, Jacob Michael Vogan
  • Publication number: 20240271170
    Abstract: Provided are non-naturally occurring polynucleotide sequences that encode for polypeptides useful in ergoline biosynthesis, as well as the non-naturally occurring polypeptide sequences. Also provided are recombinant host cell and methods for microbial biosynthesis of an ergoline, or a precursor or metabolite thereof, using the recombinant host cell.
    Type: Application
    Filed: September 21, 2023
    Publication date: August 15, 2024
    Inventors: Erin Marie Scott, Jacob Michael Vogan, Kirsten Tang, James Wade
  • Patent number: 11987602
    Abstract: The methods and systems disclose enzymes that function to import malonic acid or malonates into a cell. The enzymes increase the output of precursor molecules by enriching certain pathways in the cell. The precursor molecules can be converted to cannabinoids. The enzymes are a family of proteins which have a majority of common alignments.
    Type: Grant
    Filed: June 16, 2021
    Date of Patent: May 21, 2024
    Assignee: CB Therapeutics, Inc.
    Inventors: Erin Marie Scott, Jacob Michael Vogan
  • Publication number: 20240124905
    Abstract: Provided is a nucleic acid comprising a recombinant bacterial or archaeal geranyl pyrophosphate synthase (GPPS) gene, codon optimized for production in yeast. Also provided is a yeast cell comprising an expression cassette comprising the above nucleic acid. Additionally provided is a method of producing a terpene or cannabinoid in a yeast, the method comprising incubating the above yeast cell in a manner sufficient to produce the terpene or cannabinoid.
    Type: Application
    Filed: January 26, 2022
    Publication date: April 18, 2024
    Inventors: Erin Marie SCOTT, Kirsten TANG, Jacob Michael VOGAN
  • Publication number: 20230383314
    Abstract: Provided is an engineered olivetolic acid cyclase (OAC) enzyme derived from a microorganism or non-Cannabis plant, wherein the enzyme catalyzes cyclization of a polyketide (I) into a resorcyclic acid derivative (II), where R1=CH3, CH2CH3, (CH2)2CH3, (CH2)3CH3, (CH2)4CH3, (CH2)5CH3, or (CH2)6CH3 Also provided is nucleic acids encoding the above OAC enzyme, expression cassettes comprising those nucleic acids, and recombinant microorganisms comprising those expression cassettes that express the OAC enzyme encoded therein. Additionally provided is a method of converting a polyketide (I) into a resorcyclic acid derivative (II) comprising contacting the polyketide with the above-identified OAC enzyme in a manner and for a time sufficient to convert the polyketide (I) into the resorcyclic acid derivative (II).
    Type: Application
    Filed: May 27, 2022
    Publication date: November 30, 2023
    Applicant: CB Therapeutics, Inc.
    Inventors: Erin Marie Scott, Jacob Michael Vogan, Tyler Huelsman
  • Publication number: 20230313154
    Abstract: Provided is a nucleic acid comprising a sequence encoding a prenyltransferase (PT) gene or its complement, codon optimized for production in a microorganism or a plant. Also provided is a yeast expression cassette comprising the above nucleic acid. Additionally provided is a non-naturally occurring prenyltransferase (PT) comprising an amino acid sequence having at least 90% amino acid sequence identity or conservative amino acid substitutions to the amino acid sequences encoded by the above nucleic acid. Further provided is a recombinant microorganism or plant expressing a PT encoded by the above nucleic acid. Additionally provided is a method of catalyzing the condensation of a polyprenol diphosphate and an alkylresorcinol or alkylresorcyclic acid to yield a cannabinoid.
    Type: Application
    Filed: July 16, 2021
    Publication date: October 5, 2023
    Applicant: CB THERAPEUTICS, INC.
    Inventors: Erin Marie Scott, Jacob Michael Vogan, Tyrone Jacob Yacoub
  • Publication number: 20220298533
    Abstract: Provided is a method of modifying a first cannabinoid into a second cannabinoid or a non-cannabinoid. The method comprises combining the first cannabinoid with an enzyme that can modify the first cannabinoid into the second cannabinoid or non-cannabinoid under conditions where the first cannabinoid is modified into the second cannabinoid or non-cannabinoid. Also provided is a non-naturally occurring enzyme that can modify a first cannabinoid into a second cannabinoid or a non-cannabinoid. A nucleic acid encoding that enzyme is additionally provided. Further provided is a non-naturally occurring nucleic acid that encodes an enzyme having the enzymatic activity of the above non-naturally occurring enzyme. An expression cassette comprising that nucleic acid is additionally provided. A cell comprising the above expression cassette is further provided. Also provided is a plant expression cassette comprising the above-identified nucleic acid.
    Type: Application
    Filed: March 22, 2022
    Publication date: September 22, 2022
    Applicant: CB Therapeutics, Inc.
    Inventors: Erin Marie Scott, Jacob Michael Vogan
  • Publication number: 20210388035
    Abstract: The methods and systems disclose enzymes that function to import malonic acid or malonates into a cell. The enzymes increase the output of precursor molecules by enriching certain pathways in the cell. The precursor molecules can be converted to cannabinoids. The enzymes are a family of proteins which have a majority of common alignments.
    Type: Application
    Filed: June 16, 2021
    Publication date: December 16, 2021
    Applicant: CB Therapeutics, Inc.
    Inventors: Erin Marie Scott, Jacob Michael Vogan
  • Patent number: 11041002
    Abstract: The methods and systems disclose enzymes that function to import malonic acid or malonates into a cell. The enzymes increase the output of precursor molecules by enriching certain pathways in the cell. The precursor molecules can be converted to cannabinoids. The enzymes are a family of proteins which have a majority of common alignments.
    Type: Grant
    Filed: September 3, 2019
    Date of Patent: June 22, 2021
    Assignee: CB THERAPEUTICS, INC.
    Inventors: Erin Marie Scott, Jacob Michael Vogan